Apogee Therapeutics (APGE)
135.07
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 15-12G Apogee Therapeutics,
September 14, 2026 6:03 AM - SEC Filing
AbbVie completes $10.9B acquisition of Apogee Therapeutics
September 3, 2026 8:35 AM - StreetInsider
Apogee Therapeutics Inc (APGE) PT Raised to $135 at Truist Securities
August 13, 2026 7:09 AM - StreetInsider
BTIG Downgrades Apogee Therapeutics Inc (APGE) to Neutral
August 12, 2026 6:06 AM - StreetInsider
Form 4 Apogee Therapeutics, For: Aug 07 Filed by: Harwin Peter Evan
August 11, 2026 4:31 PM - SEC Filing
Form 8-K Apogee Therapeutics, For: Aug 11
August 11, 2026 4:01 PM - SEC Filing
Form 10-Q Apogee Therapeutics, For: Jun 30
August 10, 2026 7:53 AM - SEC Filing
Form 8-K Apogee Therapeutics, For: Aug 10
August 10, 2026 7:20 AM - SEC Filing
Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates
August 10, 2026 7:00 AM - Globe NewsWire
Form 4 Apogee Therapeutics, For: Aug 05 Filed by: Dambkowski Carl
August 7, 2026 8:00 PM - SEC Filing
Form DEFA14A Apogee Therapeutics,
August 6, 2026 6:31 AM - SEC Filing
Form DEFA14A Apogee Therapeutics,
August 3, 2026 5:10 PM - SEC Filing
Form 4 Apogee Therapeutics, For: Jul 24 Filed by: Henderson Jane
July 24, 2026 8:01 PM - SEC Filing
Form 4 Apogee Therapeutics, For: Jul 14 Filed by: Dambkowski Carl
July 16, 2026 8:00 PM - SEC Filing
Form DEFM14A Apogee Therapeutics,
July 13, 2026 5:15 PM - SEC Filing
Form 4 Apogee Therapeutics, For: Jul 08 Filed by: HENDERSON MICHAEL THOMAS
July 10, 2026 8:00 PM - SEC Filing
Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
July 8, 2026 12:59 PM - SEC Filing
Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
July 8, 2026 11:30 AM - SEC Filing
Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: FMR LLC
July 8, 2026 10:11 AM - SEC Filing
Form 4 Apogee Therapeutics, For: Jul 01 Filed by: Dambkowski Carl
July 2, 2026 8:13 PM - SEC Filing
Form PREM14A Apogee Therapeutics, For: Jul 02
July 2, 2026 5:24 PM - SEC Filing
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders
July 2, 2026 5:35 AM - StreetInsider
Form 144 Apogee Therapeutics, Filed by: Dambkowski Carl
July 1, 2026 5:00 PM - SEC Filing
Form DEFA14A Apogee Therapeutics,
June 26, 2026 5:25 PM - SEC Filing
Form 4 Apogee Therapeutics, For: Jun 22 Filed by: Dambkowski Carl
June 24, 2026 8:02 PM - SEC Filing
Form 4 Apogee Therapeutics, For: Jun 22 Filed by: HENDERSON MICHAEL THOMAS
June 24, 2026 8:01 PM - SEC Filing
Stifel Downgrades Apogee Therapeutics Inc (APGE) to Hold
June 24, 2026 9:30 AM - StreetInsider
Mizuho Downgrades Apogee Therapeutics Inc (APGE) to Neutral
June 24, 2026 4:12 AM - StreetInsider
Form SCHEDULE 13D/A Apogee Therapeutics, Filed by: Fairmount Funds Management LLC
June 23, 2026 5:00 PM - SEC Filing
TD Cowen Downgrades Apogee Therapeutics Inc (APGE) to Hold
June 23, 2026 4:37 PM - StreetInsider
Guggenheim Downgrades Apogee Therapeutics Inc (APGE) to Neutral
June 23, 2026 8:16 AM - StreetInsider
Apogee Therapeutics Inc (APGE) PT Raised to $135 at RBC Capital
June 23, 2026 6:58 AM - StreetInsider
UBS Downgrades Apogee Therapeutics Inc (APGE) to Neutral
June 23, 2026 3:07 AM - StreetInsider
Form DEFA14A Apogee Therapeutics,
June 22, 2026 5:10 PM - SEC Filing
Form 144 Apogee Therapeutics, Filed by: Dambkowski Carl
June 22, 2026 4:49 PM - SEC Filing
Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
June 22, 2026 3:44 PM - StreetInsider
Craig-Hallum Downgrades Apogee Therapeutics Inc (APGE) to Hold
June 22, 2026 12:31 PM - StreetInsider
Wedbush Downgrades Apogee Therapeutics Inc (APGE) to Neutral
June 22, 2026 10:56 AM - StreetInsider
Form 144 Apogee Therapeutics, Filed by: HENDERSON MICHAEL THOMAS
June 22, 2026 10:40 AM - SEC Filing
Apogee Therapeutics, BitFuFu rise premarket; AbbVie gains after deal
June 22, 2026 10:16 AM - StreetInsider
Canaccord Downgrades Apogee Therapeutics Inc (APGE) to Hold
June 22, 2026 9:10 AM - StreetInsider
Form DEFA14A Apogee Therapeutics,
June 22, 2026 7:46 AM - SEC Filing
Form 8-K Apogee Therapeutics, For: Jun 18
June 22, 2026 7:45 AM - SEC Filing
Form 8-K Apogee Therapeutics, For: Jun 17
June 22, 2026 7:23 AM - SEC Filing
AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
June 22, 2026 7:01 AM - StreetInsider
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
June 22, 2026 7:00 AM - PR NewsWire
Apogee Therapeutics (APGE) call put ratio 1.1 calls to 1 put into share price up before the bell
June 22, 2026 6:22 AM - StreetInsider
Full Article List
